Impact of 5-aza-2'-deoxycytidine and epigallocatechin-3-gallate for induction of human regulatory T cells

Immunology

Volumn 142, Issue 3, 2014, Pages 384-395

  Kehrmann, Jan ^a   Tatura, Roman ^a   Zeschnigk, Michael ^a   Probst Kepper, Michael ^b   Geffers, Robert ^c   Steinmann, Joerg ^a   Buer, Jan ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b KLINIKUM BRAUNSCHWEIG   (Germany)

^c HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

Author keywords

5 Aza dC; Decitabine; Epigallocatechin 3 gallate; Methylation; Regulatory T cell

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; DNA METHYLTRANSFERASE INHIBITOR; EPIGALLOCATECHIN GALLATE; TRANSCRIPTION FACTOR FOXP3;

AMPLICON; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CELL FUNCTION; CELL LINEAGE; CELL TRANSFER; CELL VIABILITY; CONTROLLED STUDY; DEMETHYLATION; DNA METHYLATION; ENZYME ACTIVE SITE; EPIGENETICS; GENE CONTROL; HUMAN; HUMAN CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; STABLE EXPRESSION; TH1 CELL; TH17 CELL;

5-AZA-DC; DECITABINE; EPIGALLOCATECHIN-3-GALLATE; METHYLATION; REGULATORY T CELL;

AZACITIDINE; CATECHIN; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; MALE; METHYLATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; T-LYMPHOCYTES, REGULATORY;

EID: 84901985343     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/imm.12261     Document Type: Article

References (30)

1. + regulatory T cells in human autoimmune diseases. Nat Rev Immunol 2010; 10:849-59.
2. + regulatory T cells (Tregs) after CD25-depleted allotransplantation in elderly patients and association with acute graft-versus-host disease. Blood 2007; 110:1689-97.
3. Brunstein CG, Miller JS, Cao Q et al. Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics. Blood 2011; 117:1061-70.
4. Di Ianni M, Falzetti F, Carotti A et al. Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation. Blood 2011; 117:3921-8.
5. + regulatory T cells for the treatment of Graft-versus-host disease. Arch Immunol Ther Exp (Warsz) 2012; 60:183-90.
6. Huehn J, Polansky JK, Hamann A. Epigenetic control of FOXP3 expression: the key to a stable regulatory T-cell lineage? Nat Rev Immunol 2009; 9:83-9.
7. + conventional T cells. Eur J Immunol 2007; 37:2378-89.
8. + FOXP3 T cells by T-cell receptor stimulation is transforming growth factor-β dependent but does not confer a regulatory phenotype. Blood 2007; 110:2983-90.
9. Floess S, Freyer J, Siewert C et al. Epigenetic control of the foxp3 locus in regulatory T cells. PLoS Biol 2007; 5:e38.
10. Probst-Kepper M, Geffers R, Kroger A et al. GARP: a key receptor controlling FOXP3 in human regulatory T cells. J Cell Mol Med 2009; 13:3343-57.
11. + Tregs. J Clin Invest 2005; 115:3276-84.
12. Kehrmann J, Zeschnigk M, Buer J, Probst-Kepper M. FOXP3 expression in GARP-transduced helper T cells is not associated with FOXP3 TSDR demethylation. Transfus Med Hemother 2011; 38:287-91.
13. Estey EH. Epigenetics in clinical practice: the examples of azacitidine and decitabine in myelodysplasia (MDS) and acute myeloid (AML). Leukemia 2013; 27:1803-12.
14. Goodyear OC, Dennis M, Jilani NY et al. Azacitidine augments expansion of regulatory T cells after allogeneic stem cell transplantation in patients with acute myeloid leukemia (AML). Blood 2012; 119:3361-9.
15. Schroeder T, Frobel J, Cadeddu RP et al. Salvage therapy with azacitidine increases regulatory T cells in peripheral blood of patients with AML or MDS and early relapse after allogeneic blood stem cell transplantation. Leukemia 2013; 27:1910-3.
16. Costantini B, Kordasti SY, Kulasekararaj AG et al. The effects of 5-azacytidine on the function and number of regulatory T cells and T-effectors in myelodysplastic syndrome. Haematologica 2013; 98:1196-205.
17. Steinmann J, Buer J, Pietschmann T, Steinmann E. Anti-infective properties of epigallocatechin-3-gallate (EGCG), a component of green tea. Br J Pharmacol 2013; 168:1059-73.
18. Wu D, Wang J, Pae M, Meydani SN. Green tea EGCG, T cells, and T cell-mediated autoimmune diseases. Mol Aspects Med 2012; 33:107-18.
19. Fang MZ, Wang Y, Ai N, Hou Z, Sun Y, Lu H, Welsh W, Yang CS. Tea polyphenol (-)-epigallocatechin-3-gallate inhibits DNA methyltransferase and reactivates methylation-silenced genes in cancer cell lines. Cancer Res 2003; 63:7563-70.
20. Lee WJ, Shim JY, Zhu BT. Mechanisms for the inhibition of DNA methyltransferases by tea catechins and bioflavonoids. Mol Pharmacol 2005; 68:1018-30.
21. Wong CP, Nguyen LP, Noh SK, Bray TM, Bruno RS, Ho E. Induction of regulatory T cells by green tea polyphenol EGCG. Immunol Lett 2011; 139:7-13.
22. Tatura R, Zeschnigk M, Adamzik M, Probst-Kepper M, Buer J, Kehrmann J. Quantification of regulatory T cells in septic patients by real-time PCR-based methylation assay and flow cytometry. PLoS One 2012; 7:e49962.
23. Josefowicz SZ, Lu LF, Rudensky AY. Regulatory T cells: mechanisms of differentiation and function. Annu Rev Immunol 2012; 30:531-64.
24. Stockis J, Colau D, Coulie PG, Lucas S. Membrane protein GARP is a receptor for latent TGF-β on the surface of activated human Treg. Eur J Immunol 2009; 39:3315-22.
25. Christman JK. 5-Azacytidine 5-aza-2'-deoxycytidine as inhibitors of DNA methylation: mechanistic studies their implications for cancer therapy. Oncogene 2002; 21:5483-95.
26. Lee TT, Karon MR. Inhibition of protein synthesis in 5-azacytidine-treated HeLa cells. Biochem Pharmacol 1976; 25:1737-42.
27. Battaglia M, Roncarolo MG. The Tregs' world according to GARP. Eur J Immunol 2009; 39:3296-300.
28. Cohen CJ, Crome SQ, MacDonald KG, Dai EL, Mager DL, Levings MK. Human Th1 and Th17 cells exhibit epigenetic stability at signature cytokine and transcription factor loci. J Immunol 2011; 187:5615-26.
29. Tang Q, Lee K. Regulatory T-cell therapy for transplantation: how many cells do we need? Curr Opin Organ Transplant 2012; 17:349-54.
30. Maeder ML, Angstman JF, Richardson ME et al. Targeted DNA demethylation and activation of endogenous genes using programmable TALE-TET1 fusion proteins. Nat Biotechnol 2013; 31:1137-42.